PMC:7307149 / 614-858 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T8","span":{"begin":78,"end":81},"obj":"Body_part"},{"id":"T9","span":{"begin":182,"end":214},"obj":"Body_part"},{"id":"T10","span":{"begin":216,"end":219},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma84079"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma84079"}],"text":"gainst SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.\n\nAbstract\nABSTRACT\nGenetic variability across the three major histocompatibility complex (MHC) class I genes (human le"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T6","span":{"begin":7,"end":15},"obj":"Disease"},{"id":"T7","span":{"begin":41,"end":49},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"gainst SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.\n\nAbstract\nABSTRACT\nGenetic variability across the three major histocompatibility complex (MHC) class I genes (human le"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":23,"end":28},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T8","span":{"begin":229,"end":234},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T9","span":{"begin":236,"end":241},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"gainst SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.\n\nAbstract\nABSTRACT\nGenetic variability across the three major histocompatibility complex (MHC) class I genes (human le"}

{"project":"LitCovid-PubTator","denotations":[{"id":"9","span":{"begin":7,"end":17},"obj":"Species"},{"id":"13","span":{"begin":41,"end":49},"obj":"Disease"},{"id":"47","span":{"begin":236,"end":241},"obj":"Species"}],"attributes":[{"id":"A9","pred":"tao:has_database_id","subj":"9","obj":"Tax:2697049"},{"id":"A13","pred":"tao:has_database_id","subj":"13","obj":"MESH:C000657245"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"gainst SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.\n\nAbstract\nABSTRACT\nGenetic variability across the three major histocompatibility complex (MHC) class I genes (human le"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":182,"end":214},"obj":"http://purl.obolibrary.org/obo/GO_0046776"},{"id":"T3","span":{"begin":216,"end":219},"obj":"http://purl.obolibrary.org/obo/GO_0046776"}],"text":"gainst SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.\n\nAbstract\nABSTRACT\nGenetic variability across the three major histocompatibility complex (MHC) class I genes (human le"}

{"project":"LitCovid-sentences","denotations":[{"id":"T9","span":{"begin":127,"end":135},"obj":"Sentence"},{"id":"T10","span":{"begin":136,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"gainst SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.\n\nAbstract\nABSTRACT\nGenetic variability across the three major histocompatibility complex (MHC) class I genes (human le"}